{"title":"Rewards for cancer control with use of biologic markers and end points.","authors":"P Kotin","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The increasing availability of biologic markers and end points offers significant potential for improvement in cancer control. These tools are underutilized today, but it is clear that they can be major assets to pathologists, clinicians, epidemiologists, and ultimately to programs designed for preventive or therapeutic intervention in populations and individuals at high cancer risk.</p>","PeriodicalId":76196,"journal":{"name":"National Cancer Institute monograph","volume":"67 ","pages":"129-32"},"PeriodicalIF":0.0000,"publicationDate":"1985-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"National Cancer Institute monograph","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The increasing availability of biologic markers and end points offers significant potential for improvement in cancer control. These tools are underutilized today, but it is clear that they can be major assets to pathologists, clinicians, epidemiologists, and ultimately to programs designed for preventive or therapeutic intervention in populations and individuals at high cancer risk.
分享
京公网安备 11010802042870号
京ICP备2023020795号-1
求助内容：
应助结果提醒方式：
扫码关注我们
